A cytosine-adenosine (CA) repeat sequence polymorphism in the IGF-I promoter region of humans may influence IGF-I production and showed association with myocardial infarction, type 2 diabetes [11], bone mineral density [12], risk of heart failure [13], low birthweight [14] and breast cancer [15]. This evidence concerns the gene IGF1 and breast cancer.